APA

Chauvier D., Renolleau S., Holifanjaniaina S., Ankri S., Bezault M., Schwendimann L., Rousset C., Casimir R., Hoebeke J., Smirnova M., Debret G., Trichet A., Carlsson Y., Wang X., Bernard E., Hébert M., Rauzier J., Matecki S., Lacampagne A., Rustin P., Mariani J., Hagberg H., Gressens P., Charriaut-Marlangue C. & Jacotot E. (20111128). Targeting neonatal ischemic brain injury with a pentapeptide-based irreversible caspase inhibitor. : Cell death & disease.

Chicago

Chauvier D, Renolleau S, Holifanjaniaina S, Ankri S, Bezault M, Schwendimann L, Rousset C, Casimir R, Hoebeke J, Smirnova M, Debret G, Trichet A-P, Carlsson Y, Wang X, Bernard E, Hébert M, Rauzier J-M, Matecki S, Lacampagne A, Rustin P, Mariani J, Hagberg H, Gressens P, Charriaut-Marlangue C and Jacotot E. 20111128. Targeting neonatal ischemic brain injury with a pentapeptide-based irreversible caspase inhibitor. : Cell death & disease.

Harvard

Chauvier D., Renolleau S., Holifanjaniaina S., Ankri S., Bezault M., Schwendimann L., Rousset C., Casimir R., Hoebeke J., Smirnova M., Debret G., Trichet A., Carlsson Y., Wang X., Bernard E., Hébert M., Rauzier J., Matecki S., Lacampagne A., Rustin P., Mariani J., Hagberg H., Gressens P., Charriaut-Marlangue C. and Jacotot E. (20111128). Targeting neonatal ischemic brain injury with a pentapeptide-based irreversible caspase inhibitor. : Cell death & disease.

MLA

Chauvier D, Renolleau S, Holifanjaniaina S, Ankri S, Bezault M, Schwendimann L, Rousset C, Casimir R, Hoebeke J, Smirnova M, Debret G, Trichet A-P, Carlsson Y, Wang X, Bernard E, Hébert M, Rauzier J-M, Matecki S, Lacampagne A, Rustin P, Mariani J, Hagberg H, Gressens P, Charriaut-Marlangue C and Jacotot E. Targeting neonatal ischemic brain injury with a pentapeptide-based irreversible caspase inhibitor. : Cell death & disease. 20111128.